潜在抗抑郁药的结合性亲和和和机制针对人类NMDA受体
Simin Ye1,2, Yanqiang Han2, Zhiyun Wei1
1Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Molecules (Basel, Switzerland)
|June 10, 2023
概括
罗25-6981对NMDA受体表现出最强的结合亲和力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
背景情况:
- 抑郁症是一个全球性的心理健康挑战,需要新的,快速起作用的治疗方法.
- N-甲基-D-酸 (NMDA) 受体的跨膜域 (TMD) 是抗抑郁药开发的有希望的目标.
- 了解NMDA受体的药物结合机制对于设计有效疗法至关重要.
研究的目的:
- 研究八种向NMDA受体的药物的结合亲和力和结合机制.
- 为了确定潜在的化合物用于快速起作用的抗抑郁药的开发.
- 阐明药物与NMDA受体TMD之间的分子相互作用.
主要方法:
- 使用联结蛋白对接模拟来预测结合模式.
- 用分子动力学模拟来分析药物受体相互作用.
- 自由能量分解分析确定了关键的结合点残留物.
主要成果:
- 罗25-6981对NMDA受体TMD表现出最高的结合亲和力.
- 与S-ketamine相比,R-ketamine表现出更强的结合能力.
- 发现残留物Leu124和Met63对于结合能量的贡献至关重要.
结论:
- 罗25-6981是基于NMDA受体的有效抑郁症治疗的潜在候选者.
- 计算方法为开发新型抗抑郁药提供了宝贵的见解.
- 这项研究提供了针对抑郁症治疗中的NMDA受体的计算参考.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
280
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
280
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Antidepressant Drugs: Overview
604
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
604
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Ligand-gated Ion Channels
12.5K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.5K
Long-term Depression
31.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.1K


